JPRN-UMIN000052228RecruitingUnknown
Efficacy and safety of initial treatment (combination immunotherapy or chemotherapy + ICI) in advanced non-small cell lung cancer patients (TPS 1-49%): A multicenter retrospective observational study (TOPGAN2023-01) - Efficacy and safety of initial treatment (combination immunotherapy or chemotherapy + ICI) in advanced non-small cell lung cancer patients (TPS 1-49%): A multicenter retrospective observational study (TOPGAN2023-01)
department of respiratory medicine hirosaki university graduate school of medicine0 sites300 target enrollmentStarted: September 18, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Recruiting
- Sponsor
- Enrollment
- 300
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to 100years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1 Positive for genetic mutations (EGFR common mutation/ALK), LCNEC 2 The attending physician has deemed the patient ineligible for registration in this study. 3 Has an active concurrent cancer that affects prognosis
Investigators
Similar Trials
Completed
Phase 3
Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study)Type 2 DiabetesTCTR20191213002G Life Sciences433
Completed
Phase 2
Efficacy and feasibility of first-line treatment with risk-adapted dose-adjusted EPOCH-R (DA-EPOCH-R) in patients with Burkitt lymphoma. A phase II clinical trial.Burkitt lymphomahighly aggressive B cell lymphoma10025320NL-OMON36941Vrije Universiteit Medisch Centrum22
Active, not recruiting
Not Applicable
A trial to investigate treatment with EPOCH-R in patients with Burkitt lymphoma, by adapting the dose to the risk classification of the disease.Burkitt lymphomaMedDRA version: 14.1Level: HLTClassification code 10006596Term: Burkitt's lymphomasSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2012-003141-16-NLVU University Medical Center
Completed
Not Applicable
Assessment of safety and initial therapeutic efficacy of non-damaging patterned scanning laser phototherapy in patients with diffuse diabetic macular edemaDiffuse diabetic macular edemaJPRN-UMIN000012401agoya City University Gradate School of Medical Sciences10
Active, not recruiting
Not Applicable
COMET TrialJPRN-jRCTs031180210Yokote Koutaro60